Astellas Attempts To Oust OSI Board In Takeover Bid
Japanese pharmaceutical giant Astellas Pharma Inc. wants to replace the board of OSI Pharmaceutical with its own nominees as it pushes forward with its $3.5 billion hostile takeover bid....To view the full article, register now.
Already a subscriber? Click here to view full article